Dark

NVTA
INVITAE CORP
stock NYSE

Inactive

Feb 14, 2024

0.0190USD-35.593%(-0.0105)22,459,258

Pre-market

0.00USD-100.000%(-0.03)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 10, 2022

07:21AM EST Invitae Expects 2021 Revenue to be At Least $458M Vs $465M Est Benzinga

07:10AM EST Invitae Corporation (NVTA) reported preliminary 2021 revenue of more than $458 million, an approximate 64 percent increase from $279.6 million, prior year. Billable volume was more than 1.16 million in 2021, an approximate 76 percent increase from billable volume of 659,000 in 2020. The company ended the year with more than 17,500 active healthcare provider accounts. RTTNews

07:02AM EST Invitae Reports 64% Growth Year-over-year In FY Revenues RTTNews

06:59AM EST Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable PR Newswire

Jan 5, 2022

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

07:31AM EST Invitae to Present Virtually at the 40th Annual J.P. Morgan Healthcare PR Newswire

Nov 9, 2021

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:35AM EST Raymond James Maintains Outperform on Invitae, Lowers Price Target to $36 Benzinga

11:06AM EST Invitae Sees FY21 Sales $450M-$475M vs $484.54M Est. Benzinga

11:06AM EST Invitae Q3 Adj. EPS $(0.81) Misses $(0.71) Estimate, Sales $114.39M Miss $126.55M Estimate Benzinga

Nov 8, 2021

04:06PM EST Invitae Reports $114.4 Million in Revenue Driven by 296,000 in Billable Volume PR Newswire

08:29AM EST The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Benzinga

08:02AM EST Importance of Genetic Testing for Cardiovascular Conditions at the American Heart Association Scientific Sessions PR Newswire

05:06AM EST Earnings Scheduled For November 8, 2021 Benzinga

Nov 5, 2021

11:16AM EDT Invitae's Earnings: A Preview Benzinga

Oct 26, 2021

07:31AM EDT Invitae to Announce Third Quarter 2021 Financial Results on Monday, November 8, PR Newswire

Oct 22, 2021

08:08AM EDT Invitae, UCL And Francis Crick Institute Announce New Data From TRACERx Research Collaboration RTTNews

08:05AM EDT Invitae, UCL And The Francis Crick Institute Announce New Data From TRACERx Research Collaboration At The 2021 International Society Of Liquid Biopsy Congress Benzinga

08:01AM EDT Research Collaboration at the 2021 International Society of Liquid Biopsy Congress PR Newswire

Sep 25, 2021

12:15PM EDT New Study Highlights the Value of Genetic Testing to Guide Clinical Management PR Newswire

Sep 14, 2021

07:30AM EDT Dante Labs, a global leader in genomics and precision medicine, today announced the appointments of Andre Nel, Dalila Rahmani, Laura DAngelo and Omar Elbakshish to the companys management team, expanding its global leadership to help scale the growing business. GlobeNewswire Inc

Sep 7, 2021

11:01AM EDT Invitae Strengthens Health Data Platform With Ciitizen Acquisition Benzinga

08:23AM EDT Invitae (NVTA) has entered into a definitive agreement to acquire Ciitizen, a consumer health tech company. Under the agreement, Invitae will acquire Ciitizen for approximately $325 million, consisting of approximately $125 million in cash and approximately 7.07 million shares of Invitae common stock. RTTNews

07:22AM EDT Invitae To Buy Ciitizen For About $325 Mln RTTNews

07:06AM EDT Invitae To Acquire Ciitizen For $325M Benzinga

07:01AM EDT Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data PR Newswire

Sep 1, 2021

07:31AM EDT Invitae to Present at the Morgan Stanley 19th Annual Global Healthcare PR Newswire

Aug 20, 2021

01:49PM EDT Return on Capital Employed Overview: Invitae Benzinga

Aug 19, 2021

03:23PM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021 Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 9, 2021

04:02PM EDT Invitae to Present at the UBS Genomics 2.0 and MedTech Innovations Summit PR Newswire

Aug 5, 2021

09:15AM EDT Morgan Stanley Maintains Equal-Weight on Invitae, Lowers Price Target to $40 Benzinga

Aug 4, 2021

10:34AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021 Benzinga

08:06AM EDT Benchmark Upgrades Invitae to Buy, Announces $35 Price Target Benzinga

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Aug 3, 2021

04:38PM EDT UPDATE: Invitae Raises FY21 Sales Guidance From $450M+ To $475M-$500M vs $463M Estimate Benzinga

04:37PM EDT Invitae Q2 Adj. EPS $(0.85) Misses $(0.65) Estimate, Sales $116.30M Beat $108.30M Estimate; Raises Guidance Benzinga

04:06PM EDT Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume PR Newswire

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

03:52AM EDT Earnings Scheduled For August 3, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 22, 2021

08:22AM EDT Volpara Customers To Gain Access To Invitae Genetics Testing Services Benzinga

08:02AM EDT Volpara Collaborates With Invitae Corporation, Leading Genetics Company PR Newswire

Jul 20, 2021

10:14AM EDT Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding Benzinga

07:31AM EDT Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, PR Newswire

07:05AM EDT Pacific Biosciences Of California Reports Expansion Of Collaboration With Invitae Benzinga

07:02AM EDT Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. GlobeNewswire Inc

Jun 25, 2021

12:38PM EDT Invitae Option Alert: Jul 16 $40 Calls Sweep (33) near the Ask: 769 @ $0.35 vs 1484 OI; Earnings 8/3 After Close [est] Ref=$33.98 Benzinga

Jun 22, 2021

08:00AM EDT OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx GlobeNewswire Inc

Jun 21, 2021

07:08AM EDT Wells Fargo Maintains Equal-Weight on Invitae, Raises Price Target to $35 Benzinga

Jun 15, 2021

10:24AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 Benzinga

07:28AM EDT Raymond James Initiates Coverage On Invitae with Outperform Rating, Announces Price Target of $37 Benzinga

Jun 11, 2021

07:34AM EDT Invitae Appoints Roxi Wen As Its CFO RTTNews

07:33AM EDT Invitae Appoints Roxi Wen As Chief Financial Officer Benzinga

07:31AM EDT Invitae appoints technology and medtech veteran Roxi Wen as chief financial PR Newswire

Jun 3, 2021

10:09AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021 Benzinga

07:33AM EDT Invitae Opens Early Access To Personalized Cancer Monitoring Platform Benzinga

07:31AM EDT Invitae opens early access to liquid biopsy-based Personalized Cancer PR Newswire

06:34AM EDT Goldman Sachs Initiates Coverage On Invitae with Neutral Rating, Announces Price Target of $33 Benzinga

Jun 1, 2021

04:37PM EDT Invitae Corp Files For Offering Of Up To 26.6M Shares Of Common Stock By The Selling Stockholders Benzinga

May 25, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 Benzinga

07:31AM EDT Germline genetic testing can benefit all cancer patients as a routine practice PR Newswire

07:19AM EDT Wells Fargo Initiates Coverage On Invitae with Equal-Weight Rating, Announces Price Target of $30 Benzinga

May 21, 2021

12:36PM EDT EXCLUSIVE: Invitae CEO On Making Genetics Cost-Effective And Accessible Benzinga

May 20, 2021

07:31AM EDT Invitae to Present at the William Blair 41st Annual Growth Stock Conference PR Newswire

May 6, 2021

08:35AM EDT Morgan Stanley Maintains Equal-Weight on Invitae, Lowers Price Target to $41 Benzinga

May 5, 2021

01:53PM EDT Invitae shares were trading lower after the company reported worse-than-expected Q1 EPS results. Benzinga

09:53AM EDT Invitae Shares Trading Lower As Q1 Earnings Lag Estimates, Contracting Margins Benzinga

06:41AM EDT SVB Leerink Maintains Outperform on Invitae, Lowers Price Target to $50 Benzinga

May 4, 2021

04:55PM EDT Recap: Invitae Q1 Earnings Benzinga

04:48PM EDT Invitae Q1 EPS $(0.63) Misses $(0.59) Estimate, Sales $103.62M Beat $101.46M Estimate Benzinga

04:06PM EDT Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume PR Newswire

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

Apr 20, 2021

04:09PM EDT Invitae To Open New Facility In North Carolina Benzinga

04:06PM EDT Invitae to Open New Facility in North Carolina to Support Continued Growth PR Newswire

07:31AM EDT Invitae to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021 PR Newswire

Apr 19, 2021

10:07AM EDT AstraZeneca, Loxo Oncology At Lilly, And Invitae Join Access To Comprehensive Genomic Profiling Coalition RTTNews

10:01AM EDT AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation Join the Access to PR Newswire

Apr 15, 2021

07:31AM EDT Study finds risk-causing genetic changes in nearly 1 in 6 patients with PR Newswire

Apr 8, 2021

07:31AM EDT Invitae Joins eMERGE Network Organized By NIH As A Clinical Affiliate; Co. To Provide Genetic Testing For Study Of Up To 25,000 Petients Benzinga

07:31AM EDT Invitae joins NIH-sponsored study aimed at improving understanding of the links PR Newswire

Apr 5, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2021 Benzinga

09:29AM EDT Invitae Accelerates Personalized Oncology Testing With Genosity Acquisition Benzinga

07:58AM EDT Invitae Reports Investment Of $1.15 Bln In Convertible RTTNews

07:43AM EDT Medical genetics company Invitae Corp. (NVTA) announced Monday that it has entered into a definitive agreement to acquire genomics company Genosity Inc. for approximately $200 million, consisting of approximately $120 million in cash and approximately $80 million in shares of Invitae common stock. RTTNews

07:40AM EDT Invitae: Group Of Investors, Led By Softbank' SB Management, Will Make $1.15 Bln Investment In Convertible Senior Notes RTTNews

07:39AM EDT Invitae Announces $1.15B Investment In Its Convertible Senior Notes By Softbank Subsidiary Benzinga

07:33AM EDT Invitae To Acquire Genosity Inc. For $200 Mln RTTNews

07:32AM EDT Invitae To Acquire Genosity For $200M Consisting Of $120M In Cash And ~$80M In Invitae Stock Benzinga

07:32AM EDT Oppenheimer Upgrades Invitae to Outperform, Announces $48 Price Target Benzinga

07:30AM EDT Invitae to acquire Genosity to accelerate access to personalized oncology PR Newswire

07:30AM EDT Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives PR Newswire

06:59AM EDT Invitae Shares Are Trading Higher On SoftBank's Potential $1.2B Debt Investment: WSJ Benzinga

Apr 1, 2021

07:33AM EDT Invitae Introduces New Program To Increase Access To Genetic Testing For Adult Neurodegenerative Conditions Benzinga

07:31AM EDT Invitae introduces new program to increase access to genetic testing for adult PR Newswire

Mar 25, 2021

09:03AM EDT Let's Take A Look At This Weeks Top Performing Sectors Benzinga

Mar 11, 2021

07:31AM EST Invitae Releases Inaugural Environmental, Social and Governance (ESG) Report PR Newswire

Mar 4, 2021

07:31AM EST Invitae to Present at the Oppenheimer 31st Annual Healthcare Conference PR Newswire

Feb 24, 2021

07:31AM EST Invitae adds Medneon's risk assessment tools to its education and clinical PR Newswire

Feb 23, 2021

07:35AM EST Invitae Highlights Extended Capabilities Of Its Gia Chatbot Benzinga

07:31AM EST Invitae expands capabilities of its advanced clinical chatbot Gia, enhancing PR Newswire

Feb 22, 2021

04:06PM EST Invitae to Present at The Cowen 41st Annual Healthcare Conference PR Newswire

09:33AM EST Morgan Stanley Maintains Equal-Weight on Invitae, Raises Price Target to $45 Benzinga

Feb 18, 2021

10:25AM EST Invitae shares were trading higher after the company reported better-than-expected Q4 sales results. Ladenburg Thalmann upgraded the stock from Neutral to Buy and raised its price target from $46.50 to $58 per share. Benzinga

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021 Benzinga

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

07:38AM EST Ladenburg Thalmann Upgrades Invitae to Buy, Raises Price Target to $58 Benzinga

05:06AM EST SVB Leerink Maintains Outperform on Invitae, Raises Price Target to $65 Benzinga

Feb 17, 2021

04:21PM EST Recap: Invitae Q4 Earnings Benzinga

04:20PM EST Invitae Sees FY2021 Revs Exceeding $450M Benzinga

04:06PM EST Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable PR Newswire

04:06PM EST Invitae Q4 EPS $(0.63) Misses $(0.55) Estimate, Sales $100.40M Beat $98.40M Estimate Benzinga

04:34AM EST Earnings Scheduled For February 17, 2021 Benzinga

Feb 16, 2021

10:07AM EST Earnings Preview: Invitae Benzinga

Feb 10, 2021

07:31AM EST Invitae to Present at the 10th Annual SVB Leerink Global Healthcare Conference PR Newswire

05:20AM EST SoftBank To Invest $900M In Pacific Biosciences - WSJ Benzinga

Feb 3, 2021

07:31AM EST Invitae to Announce Fourth Quarter and Full Year 2020 Financial Results on PR Newswire

Feb 1, 2021

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2021 Benzinga

08:23AM EST Oppenheimer Downgrades Invitae to Perform Benzinga

Jan 29, 2021

07:16AM EST Decibel Therapeutics And Invitae Announce Launch Of Amplify Genetic Testing Program Benzinga

Jan 26, 2021

04:06PM EST Additional Shares of Common Stock and Closing of Underwritten Public Offering PR Newswire

Jan 22, 2021

05:35AM EST Invitae Priced 7,76M Share Public Offering of Common Stock @$51.50/Share Benzinga

Jan 21, 2021

08:50PM EST Invitae Prices Public Offering Of 7.77 Mln Common Stock At $51.50/shr RTTNews

08:38PM EST Invitae Announces Pricing of Public Offering of Common Stock PR Newswire

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

04:06PM EST Invitae Announces Proposed Public Offering of Common Stock PR Newswire

04:05PM EST Invitae Announces A $400M Share Common Stock Offering Benzinga

06:47AM EST SVB Leerink Maintains Outperform on Invitae, Raises Price Target to $64 Benzinga

Jan 14, 2021

07:35AM EST Invitae Announces Launch Of New Project With Multiple Pharmaceutical Companies To 'develop a standardized panel for MRD detection in patients with AML to support clinical trial testing across multiple drug development programs' Benzinga

07:33AM EST Biopharmaceutical Companies Select Invitae To Develop Standardized Panel To Detect MRD In Patients With AML RTTNews

07:31AM EST Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) PR Newswire

Jan 13, 2021

08:10AM EST Pacific Biosciences And Invitae To Develop 'Ultra-High-Throughput Clinical Whole Genome Sequencing Platform' Benzinga

08:02AM EST Pacific Biosciences and Invitae to Develop Ultra-High-Throughput GlobeNewswire Inc

Jan 11, 2021

10:26AM EST Looking Into Invitae's Return On Capital Employed Benzinga

07:41AM EST Invitae Sees FY21 Sales Exceeding $450M Vs. $513.7M Est. Benzinga

07:39AM EST Invitae Reports Revenue Of More Than $278 Mln In 2020 RTTNews

07:31AM EST Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in PR Newswire

Dec 29, 2020

07:31AM EST Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire

Dec 17, 2020

07:31AM EST Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses PR Newswire

Dec 15, 2020

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

Dec 9, 2020

07:35AM EST Invitae To Present New Data Supporting Genetic Testing For All Breast Cancer Patients At The 2020 San Antonio Breast Cancer Symposium Benzinga

07:30AM EST Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer PR Newswire

Dec 7, 2020

10:38AM EST Shares of medical genetic testing company Invitae Corporation (NVTA) are climbing more than 10% Monday morning and touched a new high of $56.24. RTTNews

Nov 23, 2020

06:12AM EST Invitae Announces Common Stock Offering of 5M Shares To Former Securityholders Of Archerdx, Inc. Benzinga

06:11AM EST Invitae Corp Announces U.S. FDA Accepted Submission Of A Premarket Approval Application For A Companion Diagnostic Claim For STRATAFIDE Benzinga

Nov 19, 2020

10:58AM EST New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer PR Newswire

Nov 16, 2020

11:53AM EST Invitae Shares Spike To Session High, Pullback Slightly; Traders Circulate Co. Website Outlining Co.'s COVID-19 Testing Benzinga

Nov 9, 2020

07:17AM EST Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1 Benzinga

07:00AM EST Passage Bio and Invitae Announce Collaboration to Facilitate GlobeNewswire Inc

Nov 6, 2020

11:32AM EST Morgan Stanley Maintains Equal-Weight on Invitae, Raises Price Target to $41 Benzinga

10:40AM EST SVB Leerink Maintains Outperform on Invitae, Raises Price Target to $48 Benzinga

Nov 5, 2020

04:51PM EST Invitae Q3 Adj. EPS $(0.62) Beats $(0.66) Estimate, Sales $68.70M Beat $60.10M Estimate Benzinga

04:07PM EST Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned PR Newswire

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 3, 2020

04:04AM EST SVB Leerink Maintains Outperform on Invitae, Raises Price Target to $44 Benzinga

Oct 28, 2020

07:31AM EDT Research Highlights Frequency of Genetic Risk Factors Among Men with Prostate PR Newswire

Oct 23, 2020

07:30AM EDT Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November PR Newswire

Oct 22, 2020

08:11AM EDT Invitae And Pacific Biosciences Announced That The Company's Will Collaborate To Develop Whole Genome Sequengc-Based Assays For Peduatri Epilepsy Diagnostics Benzinga

08:00AM EDT Invitae and Pacific Biosciences Collaborate to Develop Whole GlobeNewswire Inc

Oct 14, 2020

10:01AM EDT Benzinga's Top Upgrades, Downgrades For October 14, 2020 Benzinga

07:07AM EDT JP Morgan Downgrades Invitae to Neutral, Announces $45 Price Target Benzinga

Oct 8, 2020

07:31AM EDT New Study Finds Germline Genetic Testing Detects Actionable Findings Missed by PR Newswire

Oct 7, 2020

10:25AM EDT Invitae Option Alert: Oct 16 $55 Calls Sweep (14) near the Ask: 486 @ $1.2 vs 961 OI; Earnings 11/4 After Close [est] Ref=$50.35 Benzinga

Oct 6, 2020

07:02AM EDT Taysha Gene Therapies Partners with Invitae to Enable Rapid Access to Genetic Testing and Earlier Diagnosis of Patients with CNS Disease for Rare and Large-Market Indications Benzinga

Oct 5, 2020

07:55AM EDT Invitae Completes Transaction With ArcherDX RTTNews

07:31AM EDT Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer PR Newswire

Sep 11, 2020

07:31AM EDT Invitae Appoints Kimber Lockhart to its Board of Directors PR Newswire

Sep 9, 2020

09:45AM EDT Benzinga's Top Upgrades, Downgrades For September 9, 2020 Benzinga

08:01AM EDT PTC Therapeutics Launches PTC PINPOINT - A Genetic Testing Program for PR Newswire

06:11AM EDT Morgan Stanley Initiates Coverage On Invitae with Equal-Weight Rating, Announces Price Target of $38 Benzinga

Sep 3, 2020

07:48AM EDT Invitae's Debt Overview Benzinga

07:40AM EDT Invitae Announces Multi-site Study To Evaluate The Role Of Testing Guidelines In Ensuring Access To Genetic Information For Men With Prostate Cancer Benzinga

07:31AM EDT Multi-site study to evaluate the role of testing guidelines in ensuring access PR Newswire

Sep 1, 2020

07:31AM EDT Invitae to Participate in the Morgan Stanley Virtual Global Healthcare PR Newswire

Aug 21, 2020

06:48AM EDT Tesla-Heavy ETF Fund Gets Record $124M Inflow In A Day Benzinga

Aug 5, 2020

12:01PM EDT Invitae shares are trading lower after the company reported worse-than-expected Q2 EPS results on Tuesday. Benzinga

06:15AM EDT SVB Leerink Maintains Outperform on Invitae, Lowers Price Target to $34 Benzinga

Aug 4, 2020

06:38PM EDT Invitae Reports Inducement Grants Under NYSE Rule 303A.08 PR Newswire

05:15PM EDT Recap: Invitae Q2 Earnings Benzinga

04:10PM EDT Invitae Q2 EPS $(0.77) Misses $(0.70) Estimate, Sales $46.19M Beat $39.62M Estimate Benzinga

04:06PM EDT Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples PR Newswire

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Jul 21, 2020

07:05AM EDT Invitae to Announce Second Quarter 2020 Financial Results on August 4, 2020 PR Newswire

Jul 15, 2020

06:06PM EDT Delmarva Bancshares, Inc., Garrison Capital Inc., Portman Ridge Finance Corporation, Graf Industrial Corp., Invitae Corporation, Maxim Integrated Products, Analog Devices, Rexahn Pharmaceuticals, Inc., Vivint Solar, Inc. and Sunrun, Inc. PR Newswire

07:20AM EDT SVB Leerink Maintains Outperform on Invitae, Raises Price Target to $40 Benzinga

document.getElementById("NHzs1F").onerror = function(){this.style.display='none';}; .dark-mode .MfmpB5{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .MfmpB5{ color: #333333; background-color: white; border: 2px solid #333333; }NVTAINVITAE CORPstock NYSE

NVTA
INVITAE CORP
stock NYSE